Patni Rajiv
Insider CIK 1616200 · PTLA EVP, CMO · OCRX Chief Development Officer · ADMS Chief Medical Officer · RETA EVP, Chief R&D Officer · QNCX Director · BTAI Director · SEPN Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | A Award deriv | 2026-09-08 | 2026-09-10 | 275,000 | — | $0 | 275,000 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2026-09-08 | 2026-09-10 | 275,000 | — | $0 | 275,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 27,000 | — | $0 | 27,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-16 | 44,000 | — | $0 | 44,000 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 13,500 | — | $0 | 13,500 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-15 | 54,000 | — | $0 | 54,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 90,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 45,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-12 | 2023-06-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-12 | 2023-06-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 35,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 125,000 | $7.89 | $986.3K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-02-28 | 2020-03-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-02-28 | 2020-03-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2019-04-08 | 2019-04-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2019-04-08 | 2019-04-10 | 30,000 | — | $0 | 49,141 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2019-03-20 | 2019-03-21 | 2,374 | $8.00 | $19.0K | 19,141 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2018-03-21 | 2018-03-22 | 1,252 | $25.94 | $32.5K | 21,515 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2018-03-06 | 2018-03-09 | 54,750 | — | $0 | 54,750 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2018-03-06 | 2018-03-09 | 9,125 | — | $0 | 22,767 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2017-03-21 | 2017-03-22 | 733 | $17.04 | $12.5K | 13,642 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2017-01-18 | 2017-01-20 | 41,250 | — | $0 | 41,250 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2017-01-18 | 2017-01-20 | 6,875 | — | $0 | 14,375 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2016-03-04 | 2016-03-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2016-03-04 | 2016-03-08 | 7,500 | $13.66 | $102.5K | 7,500 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2015-06-08 | 2015-06-09 | 120,000 | — | $0 | 120,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2015-05-07 | 2015-05-07 | 5,050 | $3.97 | $20.0K | 5,050 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-09-02 | 2014-09-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-09-02 | 2014-09-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-09-02 | 2014-09-02 | 20,000 | — | $0 | 20,000 | SEC↗ |